The global Pharmacogenomics (PGx) market research report published by Reports and Data spans over 200+ pages and is an extensive analysis of the Pharmacogenomics (PGx) market and overall industry. The report has been formulated through thorough primary and secondary research to generate crucial statistical insights regarding market share, market size, revenue growth, CAGR, import/export, supply and demand, consumer preferences, and overall industry overview. The report discusses in detail the top companies operating in the market, their expansion strategies, product portfolio, market position, and other crucial data to offer the readers, clients, and businesses key insights and investment opportunities to gain a competitive edge over others. The report utilizes key statistical tools such as SWOT analysis, Porters Five Forces analysis, investment return analysis and feasibility analysis to offer key insights about the competitive landscape and overall market scenario.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2296
Further key findings from the report suggest
- In the product and services segment, the kits segment accounted for USD 2.70 billion in 2019 and is estimated to hold a major share of the pharmacogenomics market share through 2027 due to high product demand in research organizations for providing better insight for therapeutic decisions based on the genetic test.
- The assays segment is estimated to witness the maximum growth rate of nearly 8.4% through 2027 on account of the increasing interest of researchers, increasing preference for personalized treatment, and investment in the safety and efficiency of drugs.
- In terms of technology, the Polymerase Chain Reaction (PCR) segment is expected to account for major pharmacogenomics market revenue share through 2027. The technology has the potential to aid the development of effective and safe medications tailored to an individual’s genetic make-up, which is leading to high demand.
- On the basis of application, the cardiovascular segment is estimated to contribute significantly to the pharmacogenomics market share, exhibiting a CAGR of 8.1% through 2027 due to the increasing prevalence of cardiovascular diseases across the globe.
- In the regional landscape, North America dominated the market share with a revenue generation of USD 2.33 billion in 2019 and is set to witness a substantial growth due to the availability of the best in class healthcare infrastructure along with increased demand for pharmacogenomics for the treatment of chronic diseases in the region.
- The Asia Pacific region is estimated to witness major growth through 2027 due to changing lifestyles and a rise in the patient pool suffering from various target diseases. A recent study indicated that the current growth rate for federal research funding in China has exponentially exceeded that in the European Union and the U.S.
- Europe accounted for 27.5% of the pharmacogenomics market share in 2019 and is set to witness a growth rate of 8.4% over the analysis period.
Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2296
The report discusses in detail the top companies in the market along with their recent initiatives such as mergers and acquisitions, joint venture, partnerships, corporate and government deals, collaborations, and brand promotions and product launches among others. The report further discusses the companies’ initiatives and investments in key regions across the globe such as North America, Europe, Latin America, Asia Pacific, and Middle East & Africa.
Region analysis Covers:
North America (U.S.A., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of Europe)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
For the purpose of this report, Reports and Data has segmented the Global Pharmacogenomics (PGx) Market on the basis of products and services, technology, application, end-use, and region
Products and Services Outlook (Revenue, USD Billion; 2017-2027)
Products
Kits
Assay & Reagents
Instruments
Software
Services
Genotyping
SNP Identification
Pharmacogenetics Testing
Other Services
Technology Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction (PCR)
Real Time PCR
qPCR
Digital PCR
DNA Sequencing/Next Generation Sequencing (NGS)
Nucleic Acid Amplification Tests (NAATs)
Mass Spectrometry
Gel Electrophoresis
Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Others
Microarray
Others
Application Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Infectious Diseases
Neurology/Psychiatry
Cardiovascular
Others
End-Use Outlook (Revenue, USD Billion; 2017-2027)
Research Organisation
Pharmaceutical Companies
Diagnostic Centers
Others
To know more about the report @ https://www.reportsanddata.com/press-release/global-pharmacogenomics-pgx-market
Top Companies operating in the Market and Profiled in the Report include:
Admera Health
Abbott Laboratories
Agena Biosciences
Inc., Dynamic DNA Laboratories
Cancer Genetics
F. Hoffmann-La Roche Lt
Genomic Health
GeneOmbio Technologies Pvt Ltd.
Laboratory Corporation of America Holdings
IlluminaIn
Read More Reports
Biosimilars Market – https://www.reportsanddata.com/report-detail/global-biosimilars-market
Dry Powder Inhaler Device Market – https://www.reportsanddata.com/report-detail/dry-powder-inhaler-device-market
Hemolysis Agent for Blood Cell Analyzer Market – https://www.reportsanddata.com/report-detail/hemolysis-agent-for-blood-cell-analyzer-market
Oxycodone Market – https://www.reportsanddata.com/report-detail/oxycodone-market
Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
